儿童肺炎支原体肺炎呼吸道病原多重检测的多中心研究
该前瞻性多中心研究纳入2023年11月15日至12月20日4家医院298例MPP患儿,分析呼吸道多重PCR病原检出状况及临床特征。结果显示重症组多病原共检出率、LDH、D二聚体均高于轻症组,重症MPP中共检出组应激反应指标更高。
要点
- 重症MPP患儿多病原共检出率52.9%,高于轻症组36.2%(P=0.005)。
- 重症组CRP、D二聚体、LDH均高于轻症组,住院时间更长。
- 重症MPP中共检出组LDH、D二聚体、中性粒细胞计数高于单纯MP组。
核心结论
- 重症MPP患儿呼吸道病原共检出率、LDH、D二聚体高于轻症MPP患儿。
- 重症MPP中存在合并感染时患儿应激反应更强。
研究设计与样本
- 前瞻性多中心研究,收集2023年11月15日至12月20日4家医院298例诊断MPP患儿的病例资料、实验室检查及呼吸道多重核酸检测结果。
- 按病情严重度分为重症组204例与轻症组94例。
- 重症组再按是否检出MP以外病原体分为多病原共检出组89例与单纯MP组73例。
- 组间比较采用Mann-Whitney非参数秩和检验、χ²检验。
主要发现
- 298例患儿中男136例、女162例;重症组起病年龄7.0(6.0,8.0)岁,轻症组6.5(4.0,7.8)岁。
- 重症组CRP、D二聚体、LDH均高于轻症组,住院时间长于轻症组,起病至入院时间短于轻症组(均P<0.05)。
- 142例(47.7%)MPP患儿检出21种病原,常见为腺病毒25例(8.4%)、人类冠状病毒23例(7.7%)、鼻病毒21例(7.0%)、肺炎链球菌21例(7.0%)、甲型流感病毒18例(6.0%)。
- 天津、上海、温州、成都检出率最高的病原分别为金黄色葡萄球菌10.7%(8/75)、腺病毒13.0%(10/77)、腺病毒15.3%(9/59)、鼻病毒和流感嗜血杆菌均为11.5%(10/87)。
- 重症组多病原共检出率52.9%(108/204)高于轻症组36.2%(34/94)(χ²=10.62,P=0.005)。
关键数值与推荐
- 重症组与轻症组比较:CRP 10.0(5.0,18.0)比5.0(5.0,7.5)mg/L,D二聚体0.6(0.4,1.1)比0.5(0.3,0.6)mg/L,LDH 337(286,431)比314(271,393)U/L,Z=2.02、2.50、3.05,均P<0.05。
- 重症组住院时间6.0(6.0,7.0)d长于轻症组5.0(4.0,6.0)d(Z=4.37,P<0.05);起病至入院时间6.0(5.0,9.5)d短于轻症组9.0(7.0,13.0)d(Z=2.23,P=0.026)。
- 重症MPP多病原共检出组与单纯MP组比较:LDH 348(284,422)比307(270,358)U/L,D二聚体0.8(0.5,1.5)比0.6(0.4,1.0)mg/L,中性粒细胞计数4.99(3.66,6.89)×10^9比4.06(2.91,5.65)×10^9/L,Z=5.17、4.99、6.11,均P<0.05。
临床怎么用
- 对MPP患儿可开展呼吸道多重PCR检测,关注MP以外病原共检出情况。
- 重症MPP患儿应关注LDH、D二聚体、中性粒细胞计数及CRP等指标。
- 多病原共检出可能提示更强应激反应,需结合临床综合评估病情。
局限性
- 研究仅纳入2023年11月15日至12月20日4家医院298例患儿,时间与地域范围有限。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the status of respiratory pathogen detection and the clinical features in children with Mycoplasma pneumoniae pneumonia (MPP). Methods: A prospective, multicenter study was conducted to collect clinical data, including medical history, laboratory examinations and multiplex PCR tests of children diagnosed with MPP from 4 hospitals in China between November 15th and December 20th, 2023. The multiplex PCR results and clinical characteristics of MPP children in different regions were analyzed. The children were divided into severe and mild groups according to the severity of the disease. Patients in the severe group were further divided into Mycoplasma pneumoniae (MP) alone and Multi-pathogen co-detection groups based on whether other pathogens were detected besides MP, to analyze the influence of respiratory pathogen co-detection rate on the severity of the disease. Mann-Whitney rank sum test and Chi-square test were used to compare data between independent groups. Results: A total of 298 children, 136 males and 162 females, were enrolled in this study, including 204 children in the severe group with an onset age of 7.0 (6.0, 8.0) years, and 94 children in the mild group with an onset age of 6.5 (4.0, 7.8) years. The level of C-reactive protein, D-dimer, lactic dehydrogenase (LDH) were significantly higher (10.0 (5.0, 18.0) vs. 5.0 (5.0, 7.5) mg/L, 0.6 (0.4, 1.1) vs. 0.5 (0.3, 0.6) mg/L, 337 (286, 431) vs. 314 (271, 393) U/L, Z=2.02, 2.50, 3.05, all P<0.05), and the length of hospitalization was significantly longer in the severe group compared with those in mild group (6.0 (6.0, 7.0) vs. 5.0 (4.0, 6.0) d, Z=4.37, P<0.05). The time from onset to admission in severe MPP children was significantly shorter than that in mild MPP children (6.0 (5.0, 9.5) vs. 9.0 (7.0, 13.0) d, Z=2.23, P=0.026). All patients completed the multiplex PCR test, with 142 cases (47.7%) MPP children detected with 21 pathogens including adenovirus 25 cases (8.4%), human coronavirus 23 cases (7.7%), rhinovirus 21 cases (7.0%), Streptococcus pneumoniae 21 cases (7.0%), influenza A virus 18 cases (6.0%). The pathogens with the highest detection rates in Tianjin, Shanghai, Wenzhou and Chengdu were Staphylococcus aureus at 10.7% (8/75), adenovirus at 13.0% (10/77), adenovirus at 15.3% (9/59), and both rhinovirus and Haemophilus influenzae at 11.5% (10/87) each. The multi-pathogen co-detection rate in severe MPP children was significantly higher than that in mild MPP group (52.9% (108/204) vs. 36.2% (34/94), χ²=10.62,P=0.005). Among severe MPP children, there are 89 cases in the multi-pathogen co-detection group and 73 cases in the simple MPP group. The levels of LDH, D-dimer and neutrophil counts in the multi-pathogen co-detection group were significantly higher than those in the simple MPP group (348 (284, 422) vs. 307 (270, 358) U/L, 0.8 (0.5, 1.5) vs. 0.6 (0.4, 1.0) mg/L, 4.99 (3.66, 6.89)×109 vs. 4.06 (2.91, 5.65)×109/L, Z=5.17, 4.99, 6.11, all P<0.05). Conclusions: The co-detection rate of respiratory pathogens, LDH and D-dimer in children with severe MPP were higher than those with mild MPP. Among severe MPP children the stress response of children in co-detection group was more serious than that of children with simple MPP. 目的: 分析儿童肺炎支原体肺炎(MPP)呼吸道病原检测状况及临床特征。 方法: 前瞻性多中心研究,收集2023年11月15日至12月20日4家医院298例诊断为MPP患儿的一般病例资料、实验室检查及呼吸道多重核酸检测结果,分析不同地区MPP患儿呼吸道病原检测情况及临床特征。将患儿按照病情程度分为重症组和轻症组,其中重症组中根据呼吸道多重核酸检测是否检出除肺炎支原体(MP)以外的病原体分为单纯MP组和多病原共检出组,分析呼吸道病原共检出状况对病情严重度的影响。组间比较采用Mann-Whitney非参数秩和检验、χ²检验。 结果: 298例患儿中男136例、女162例。重症组204例,起病年龄7.0(6.0,8.0)岁,轻症组94例,起病年龄6.5(4.0,7.8)岁。重症组外周血C反应蛋白、D二聚体、血清乳酸脱氢酶(LDH)水平均高于轻症组[10.0(5.0,18.0)比5.0(5.0,7.5)mg/L、0.6(0.4,1.1)比0.5(0.3,0.6)mg/L、337(286,431)比314(271,393)U/L,Z=2.02、2.50、3.05,均P<0.05],住院时间长于轻症组[6.0(6.0,7.0)比5.0(4.0,6.0)d,Z=4.37,P<0.05],起病至入院时间则短于轻症组[6.0(5.0,9.5)比9.0(7.0,13.0)d,Z=2.23,P=0.026]。所有患儿均完成了呼吸道病原体多重PCR检测,共有142例(47.7%)MPP患儿检出了21种病原,其中腺病毒25例(8.4%)、人类冠状病毒23例(7.7%)、鼻病毒21例(7.0%)、肺炎链球菌21例(7.0%)、甲型流感病毒18例(6.0%)。天津、上海、温州、成都地区检出率最高的病原分别为金黄色葡萄球菌[10.7%(8/75)]、腺病毒[13.0%(10/77)]、腺病毒[15.3%(9/59)]、鼻病毒和流感嗜血杆菌[均为11.5%(10/87)]。重症组中2种及以上病原体的共检出率高于轻症组[52.9%(108/204)比36.2%(34/94),χ²=10.62,P=0.005]。多病原共检出组89例、单纯MP组73例。多病原共检出组LDH、D二聚体、中性粒细胞计数均高于单纯MP组[348(284,422)比307(270,358)U/L、0.8(0.5,1.5)比0.6(0.4,1.0)mg/L、4.99(3.66,6.89)×109比4.06(2.91,5.65)×109/L,Z=5.17、4.99、6.11,均P<0.05]。 结论: 重症MPP患儿多病原共检出率、LDH、D二聚体较高,存在合并感染的重症MPP患儿机体应激反应更强。.
引用
- Dong XY, Zou YX, Lyu FF, et al. [A multicenter study on respiratory pathogen detection with Mycoplasma pneumoniae pneumonia in children]. Zhonghua Er Ke Za Zhi. 2024. PMID: 38527500. doi:10.3760/cma.j.cn112140-20240117-00054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。